MARKET

AVCO

AVCO

AVALON GLOBOCARE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.370
-0.010
-0.42%
Opening 09:41 09/23 EDT
OPEN
2.380
PREV CLOSE
2.380
HIGH
2.390
LOW
2.370
VOLUME
3.71K
TURNOVER
--
52 WEEK HIGH
13.50
52 WEEK LOW
1.660
MARKET CAP
179.30M
P/E (TTM)
-12.7214
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AVCO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

AVCO News

  • Avalon GloboCare Announces Initiation of First-in-Human Clinical Trial of its CAR-T Candidate, AVA-001, for Treatment of B-Cell Malignancies
  • GlobeNewswire.4d ago
  • Former Dublin couple accused of stealing trade secrets from Nationwide Children's
  • American City Business Journals.5d ago
  • Avalon: Poised For Market Conquest
  • Seeking Alpha - Article.09/06 02:48
  • Avalon GloboCare Announces $20 Million Credit Facility Provided by Company Chairman
  • GlobeNewswire.09/03 13:00

More

Industry

Biotechnology & Medical Research
+0.11%
Pharmaceuticals & Medical Research
-0.03%

Hot Stocks

Name
Price
%Change

About AVCO

Avalon GloboCare Corp. is an intelligent biotech developer and healthcare service provider. The Company engages in the management of stem cell banks and specialty clinical laboratories. It is developing of exosome technology to improve the diagnosis and management of diseases. The Company operates through two platforms, Avalon Cell and Avalon Rehab. Its technology and service ecosystem covers the areas of regenerative medicine, cell-based immunotherapy, exosome technology, as well as rehabilitation medicine. The Company also focused on diagnostic advancements in the fields of oncology, infectious diseases and fibrotic diseases, and the discovery of disease-specific exosomes to provide the disease origin insight necessary to enable.
More

Webull offers Avalon Globocare Corp (AVCO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.